Literature DB >> 26740346

A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trial.

Melanie J Davies1, Laura J Gray2, Jacqui Troughton3, Alastair Gray4, Jaakko Tuomilehto5, Azhar Farooqi6, Kamlesh Khunti7, Thomas Yates8.   

Abstract

OBJECTIVES: Prevention of type 2 diabetes (T2DM) is a priority in healthcare, but there is a lack of evidence investigating how to effectively translate prevention research into a UK primary care setting. We assessed whether a structured education programme targeting lifestyle and behaviour change was effective at preventing progression to T2DM in people with pre-diabetes.
MATERIALS AND METHODS: Forty-four general practices were randomised to receive either standard care or a 6hour group structured education programme with an annual refresher course, and regular phone contact. Participants were followed up for 3years. The primary outcome was progression to T2DM.
RESULTS: Eight hundred and eighty participants were included (36% female, mean age 64years, 16% ethnic minority group); 131 participants developed T2DM. There was a non-significant 26% reduced risk of developing T2DM in the intervention arm compared to standard care (HR 0.74, 95% CI 0.48, 1.14, p=0.18). The reduction in T2DM risk when excluding those who did not attend the initial education session was also non-significant (HR 0.65, 0.41, 1.03, p=0.07). There were statistically significant improvements in HbA1c (-0.06, -0.11, -0.01), LDL cholesterol (-0.08, -0.15, -0.01), sedentary time (-26.29, -45.26, -7.32) and step count (498.15, 162.10, 834.20) when data were analysed across all time points.
CONCLUSIONS: This study suggests that a relatively low resource, pragmatic diabetes prevention programme resulted in modest benefits to biomedical, lifestyle and psychosocial outcomes, however the reduction to the risk of T2DM did not reach significance. The findings have important implications for future research and primary care.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical trial; Lifestyle; Pre-diabetes; Prevention; Type 2 diabetes

Mesh:

Year:  2015        PMID: 26740346     DOI: 10.1016/j.ypmed.2015.12.012

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  28 in total

Review 1.  Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.

Authors:  Bianca Hemmingsen; Gabriel Gimenez-Perez; Didac Mauricio; Marta Roqué I Figuls; Maria-Inti Metzendorf; Bernd Richter
Journal:  Cochrane Database Syst Rev       Date:  2017-12-04

2.  Pre-diabetes: opportunity or overdiagnosis?

Authors:  Helen Twohig; Victoria Hodges; Caroline Mitchell
Journal:  Br J Gen Pract       Date:  2018-04       Impact factor: 5.386

3.  The magnitude of type 2 diabetes mellitus and cardiovascular disease risk factors among young adults in urban settings: a cross-sectional survey in Mwanza, Tanzania.

Authors:  Evangelista Kenan Malindisa; Emmanuel Balandya; Fredirick Mashili; Shabani Iddi; Marina Njelekela
Journal:  Pan Afr Med J       Date:  2022-05-10

Review 4.  Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype.

Authors:  Matthew D Campbell; Thirunavukkarasu Sathish; Paul Z Zimmet; Kavumpurathu R Thankappan; Brian Oldenburg; David R Owens; Jonathan E Shaw; Robyn J Tapp
Journal:  Nat Rev Endocrinol       Date:  2020-02-14       Impact factor: 43.330

5.  Engagement, Retention, and Progression to Type 2 Diabetes: A Retrospective Analysis of the Cluster-Randomised "Let's Prevent Diabetes" Trial.

Authors:  Laura J Gray; Thomas Yates; Jacqui Troughton; Kamlesh Khunti; Melanie J Davies
Journal:  PLoS Med       Date:  2016-07-12       Impact factor: 11.069

6.  Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial.

Authors:  J Leal; D Ahrabian; M J Davies; L J Gray; K Khunti; T Yates; A M Gray
Journal:  BMJ Open       Date:  2017-01-09       Impact factor: 2.692

Review 7.  Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes.

Authors:  Samantha Roberts; Eleanor Barry; Dawn Craig; Mara Airoldi; Gwyn Bevan; Trisha Greenhalgh
Journal:  BMJ Open       Date:  2017-11-15       Impact factor: 2.692

8.  Searching for Real-World Effectiveness of Health Care Innovations: Scoping Study of Social Prescribing for Diabetes.

Authors:  Karen Pilkington; Martin Loef; Marie Polley
Journal:  J Med Internet Res       Date:  2017-02-02       Impact factor: 5.428

9.  The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial.

Authors:  Kar-Fu Yeung; Mihir Gandhi; Amanda Yun Rui Lam; Selly Julianty; Alvin Yeow Meng Chia; Gilbert Choon Seng Tan; Su-Yen Goh; Emily Tse Lin Ho; Angela Fang Yung Koh; Gavin Siew Wei Tan; Eugene Jin Wen Shum; Eric A Finkelstein; Tazeen H Jafar; Yee Leong Teoh; Rob M van Dam; Clare Whitton; Julian Thumboo; Yong Mong Bee
Journal:  Trials       Date:  2021-08-06       Impact factor: 2.279

10.  STEPWISE - STructured lifestyle Education for People WIth SchizophrEnia: a study protocol for a randomised controlled trial.

Authors:  Rebecca Gossage-Worrall; Richard I G Holt; Katharine Barnard; Marian E Carey; Melanie J Davies; Chris Dickens; Yvonne Doherty; Charlotte Edwardson; Paul French; Fiona Gaughran; Kathryn Greenwood; Sridevi Kalidindi; Daniel Hind; Kamlesh Khunti; Paul McCrone; Jonathan Mitchell; John Pendlebury; Shanaya Rathod; David Shiers; Najma Siddiqi; Lizzie Swaby; Stephen Wright
Journal:  Trials       Date:  2016-09-29       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.